Highlights Concord Biotech Limited

Equities

CONCORDBIO

INE338H01029

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 06:10:59 14/01/2026 pm IST			5-day change	1st Jan Change
1,351.10 ^INR	-0.07%		-0.08%	+0.41%

24/12	Concord Biotech Limited Announces Resignation of Hina Patel as Company Secretary and Compliance Officer, Effective January 21, 2026	CI
18/12	Concord Biotech Names CFO	MT

Highlights

18/12	Concord Biotech Limited Appoints Raviraj Karia as Key Managerial Personnel, Effective December 18, 2025	CI
13/11	Concord Biotech posts Sept-quarter consol net profit 635.8 million rupees	RE
13/11	Concord Biotech - approves acquisition of 100% equity in Celliimune Biotech	RE
13/11	Concord Biotech Limited Approvesl to Invest Upto INR 100 Million in Captive Hybrid Solar Power Project for Limbasi Plant	CI
13/11	Concord Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
13/11	Concord Biotech Limited agreed to acquire Celliimune Biotech Private Limited.	CI
08/25/08	Indian Regulator Completes Inspection of Concord Biotech's Gujarat, India Unit	MT
21/25/21	EU-GMP Authorities Conclude Inspection of Concord Biotech's Unit in Limbassi, India; Shares Up 3%	MT
21/25/21	Concord Biotech says EU-GMP conducts first inspection of API facility	RE
09/25/09	Concord Biotech Limited announces Annual dividend, payable on October 09, 2025	CI
08/25/08	Concord Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
22/25/22	Concord Biotech Limited Announces Incorporation of Concord Lifegen Limited as Wholly Owned Subsidiary Company	CI
18/25/18	Concord Biotech Successfully Completes EU GMP Inspection at Dholka, India Unit	MT
02/25/02	Concord Biotech Acquires 75% Stake in US-Based Stellon Biotech	MT
24/25/24	Concord Biotech Gets US FDA's Closure Report for Dholka, India Unit with 'No Regultory Action Needed'	MT
29/25/29	Concord Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025	CI
29/25/29	Concord Biotech Limited Recommends Dividend for the Financial Year 2024-25	CI
13/25/13	Concord Biotech Limited Announces Resignation of Prakash Sajnani as Company Secretary & Compliance Officer, Effective May 29, 2024	CI
09/25/09	Concord Biotech Gets US FDA Marketing Nod for Teriflunomide	MT
11/25/11	20,923,242 Equity Shares of Concord Biotech Limited are subject to a Lock-Up Agreement Ending on 11-FEB-2025.	CI
13/24/13	Jefferies Adjusts Concord Biotech's Price Target to INR1,720 From INR1,480, Keeps at Hold	MT
11/24/11	Concord Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
09/24/09	Concord Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
06/24/06	Concord Biotech Gets EU Good Manufacturing Practices Certificate for Valthera Facility in India	MT
23/24/23	Concord Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Highlights Concord Biotech Limited

Equities

CONCORDBIO

INE338H01029

Pharmaceuticals

Highlights

Filters